Blood News and Research

RSS

LBDA offers condolences over death of LBD patient

The sad news of Casey Kasem's illness and passing has brought unexpected visibility to a disease unfamiliar to many people.

20 Jun 2014

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes.

20 Jun 2014

Researchers develop tissue engineered bone grafts for healing large bone defects

Bone is one of the most frequently transplanted tissues. And the demand is rising. Transplants treat large defects like those caused by trauma, complicated fractures, tumour resection or osteoporosis.

20 Jun 2014

NIH receives $10 million grant for research on breast cancer metastasis

The American Cancer Society predicts that 40,000 American women will die from breast cancer this year. Most of those deaths will occur due to cells from the primary tumor that spread to other parts of the body-the process known as metastasis.

20 Jun 2014

New model for HIV-1 infection offers promising option for clinical research

HIV-1, the virus responsible for most cases of AIDS, is a very selective virus. It does not readily infect species other than its usual hosts — humans and chimpanzees.

20 Jun 2014

Osteoarthritis may be treated with stem cell mobilization therapy

Researchers in Taiwan have found that peripheral blood stem cells can be "mobilized" by injection of a special preparation of granulocyte colony-stimulating factor (G-CSF) into rats that modeled osteoarthritis (OA).

20 Jun 2014

Researchers shed new light on how gliomas cells migrate in brain and cause devastating tumors

Researchers at the University of Alabama at Birmingham have shed new light on how cells called gliomas migrate in the brain and cause devastating tumors.

20 Jun 2014

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

A team led by researchers from the Perelman School of Medicine at the University of Pennsylvania found that a susceptibility gene for type 1 diabetes regulates self-destruction of the cell's energy factory. They report their findings this week in Cell.

20 Jun 2014

Weizmann Institute scientists 'fingerprint' a culprit in depression and anxiety disorders

According the World Health Organization, such mood disorders as depression affect some 10% of the world's population and are associated with a heavy burden of disease. That is why numerous scientists around the world have invested a great deal of effort in understanding these diseases. Yet the molecular and cellular mechanisms that underlie these problems are still only partly understood.

20 Jun 2014

New mobile app can measure respiratory rate in children 6 times faster than manual method

A new mobile app developed by researchers at the Child & Family Research Institute (CFRI) at BC Children's Hospital and the University of British Columbia can measure respiratory rate in children roughly six times faster than the standard manual method.

20 Jun 2014

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

20 Jun 2014

Playing football could help lower blood pressure in women aged 35-50

The World Cup in Brazil may be attracting a global armchair audience of millions, but new research has shown that playing football could help lower blood pressure in women aged 35-50.

20 Jun 2014

New treatment for ovarian cancer can improve response rates

Doctors at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix reported today in Lancet Oncology that a new treatment for ovarian cancer can improve response rates (increase the rate of tumor shrinkage) and prolong the time until cancers recur.

20 Jun 2014

ChromaDex enters into joint collaboration agreement with St. Jude Children's Research Hospital

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a joint collaboration agreement with St. Jude Children's Research Hospital to evaluate ChromaDex's natural product libraries.

19 Jun 2014

Nicox launches expanded access to Sequenom Laboratories' RetnaGene portfolio

Nicox S.A., the international ophthalmic company, and Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Nicox's subsidiary, Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene™ portfolio of laboratory-developed genetic tests in the United States (U.S.).

19 Jun 2014

Research provides unique insight into lncRNAs that regulate lung development

It's a long way from DNA to RNA to protein, and only about two percent of a person's genome is eventually converted into proteins.

19 Jun 2014

Researchers discover crucial process that regulates development of blood vessels

Biologists at The Scripps Research Institute (TSRI) have discovered a crucial process that regulates the development of blood vessels.

19 Jun 2014

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

A spectacular piece of detective work has mapped a special gene variant among Greenlanders which plays a particularly important role in the development of type 2 diabetes.

19 Jun 2014

Yoga exercise program developed for patients living with pulmonary hypertension

A first-of-its-kind yoga exercise program has been developed by Henry Ford Hospital for patients living with pulmonary hypertension, a chronic lung disease that afflicts women at least two times more than men.

19 Jun 2014

Mayo Clinic study: Reversing current thought on treatment of cirrhotic patients with type 2 diabetes

Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes. The study found that the continuation of metformin after a cirrhosis diagnosis improved survival rates among diabetes patients.

19 Jun 2014

Blood News and Research

LBDA offers condolences over death of LBD patient

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

Researchers develop tissue engineered bone grafts for healing large bone defects

NIH receives $10 million grant for research on breast cancer metastasis

New model for HIV-1 infection offers promising option for clinical research

Osteoarthritis may be treated with stem cell mobilization therapy

Researchers shed new light on how gliomas cells migrate in brain and cause devastating tumors

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

Weizmann Institute scientists 'fingerprint' a culprit in depression and anxiety disorders

New mobile app can measure respiratory rate in children 6 times faster than manual method

New driver of atherosclerosis may prove to be promising therapeutic target

Playing football could help lower blood pressure in women aged 35-50

New treatment for ovarian cancer can improve response rates

ChromaDex enters into joint collaboration agreement with St. Jude Children's Research Hospital

Nicox launches expanded access to Sequenom Laboratories' RetnaGene portfolio

Research provides unique insight into lncRNAs that regulate lung development

Researchers discover crucial process that regulates development of blood vessels

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

Yoga exercise program developed for patients living with pulmonary hypertension

Mayo Clinic study: Reversing current thought on treatment of cirrhotic patients with type 2 diabetes

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News